Physician profile
Yujen Wang
NPI 1427048693
$3,688.78
in general payments reported to CMS, 2019-2025
18 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $80.75 · 2021: $255 · 2022: $482 · 2023: $332 · 2024: $897 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,033.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,051.07 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $519.04 | 2019-2025 | Vabysmo |
| Novartis Pharmaceuticals Corporation | $483.50 | 2019-2021 | |
| Alimera Sciences, INC. | $370.70 | 2019-2024 | Iluvien, Yutiq |
| Abbvie INC. | $203.43 | 2022-2025 | Ozurdex |
| Alcon Vision LLC | $149.58 | 2024 | Constellation |
| Dutch Ophthalmic, USA | $139.94 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $133.12 | 2024 | Eylea Hd |
| Astellas Pharma US INC | $122.00 | 2024 | Izervay |
| Biotissue Holdings INC. | $120.63 | 2022 | |
| Eyepoint US, INC. | $92.25 | 2021-2023 | |
| Harrow Eye, LLC | $83.60 | 2024-2025 | Iheezo |
| Allergan, INC. | $76.77 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $51.55 | 2025 | Yutiq, Iluvien |
| Sandoz INC. | $26.30 | 2024 | Cimerli |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $25.05 | 2022 | |
| Aerie Pharmaceuticals, INC. | $23.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.26 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yujen Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.